WuXi AppTec, Inc. Opens China’s First GMP Biologics Facility

by Richard Daverman, Editor

October 16, 2012 -- WuXi AppTech has officially opened its GMP manufacturing facility for biologic drugs – the first such facility in China compliant with GMP standards in China, the US and Europe. WuXi has constructed a facility that is state-of-the-art, including the first operation anywhere in the globe that uses 100% disposable equipment for producing biologics drug substances. To mark the milestone, WuXi hosted a Global Monoclonal Antibody Summit in WuXi last week, which was attended by more than 300 people. More details....

Stock Symbol: (NYSE: WX)

Back to news